静脉右酮洛芬与对乙酰氨基酚治疗急诊非创伤性肌肉骨骼疼痛:一项随机临床试验
本研究为前瞻性、随机、双盲、对照研究,在大学急诊科开展,纳入200例非创伤性肌肉骨骼疼痛患者(排除7342例),平均年龄32.6岁。患者随机接受静脉右酮洛芬50 mg或对乙酰氨基酚1000 mg,均以150 ml生理盐水快速输注,在基线、15分钟、30分钟和60分钟时采用VAS和NRS评估疼痛。结果显示两种干预均随时间降低NRS和VAS疼痛评分,而在所有疼痛部位比较中,右酮洛芬的NRS疼痛评分(p=0.001)和VAS疼痛评分(p=0.001)均统计学上优于对乙酰氨基酚。作者认为,静脉右酮洛芬似乎比对乙酰氨基酚获得更优的镇痛效果。
要点
- 研究纳入200例急诊非创伤性肌肉骨骼疼痛患者,随机接受静脉右酮洛芬50 mg或对乙酰氨基酚1000 mg,均以150 ml生理盐水快速输注。
- 两种药物均随时间降低NRS和VAS疼痛评分,评估时点为基线、15分钟、30分钟和60分钟。
- 在所有疼痛部位比较中,右酮洛芬的NRS疼痛评分统计学上优于对乙酰氨基酚(p=0.001)。
- 在所有疼痛部位比较中,右酮洛芬的VAS疼痛评分统计学上优于对乙酰氨基酚(p=0.001)。
- 作者结论认为,静脉右酮洛芬似乎在对非创伤性肌肉骨骼疼痛的镇痛方面优于静脉对乙酰氨基酚。
适用人群与场景
- 急诊科非创伤性肌肉骨骼疼痛患者,病因包括肌腱炎、肌肉痉挛、骨与关节损伤等。
- 研究在大学急诊室开展,纳入200例患者,排除7342例。
处置流程与药物剂量
- 右酮洛芬组:静脉右酮洛芬50 mg,溶于150 ml生理盐水,快速输注。
- 对乙酰氨基酚组:静脉对乙酰氨基酚1000 mg,溶于150 ml生理盐水,快速输注。
- 在基线、15分钟、30分钟和60分钟时采用VAS和NRS评估疼痛。
研究设计与关键结果
- 研究类型:前瞻性、随机、双盲、对照研究,单中心(大学急诊室),纳入200例非创伤性肌肉骨骼疼痛患者,平均年龄32.6岁。
- 干预:静脉右酮洛芬50 mg vs 静脉对乙酰氨基酚1000 mg,均溶于150 ml生理盐水快速输注。
- 两种干预均随时间降低NRS疼痛评分;在所有疼痛部位比较中,右酮洛芬的NRS疼痛评分统计学上优于对乙酰氨基酚(p=0.001)。
- 两种干预均随时间降低VAS疼痛评分;在所有疼痛部位比较中,右酮洛芬的VAS疼痛评分统计学上优于对乙酰氨基酚(p=0.001)。
证据类型、等级与局限
- 证据类型:前瞻性、随机、双盲、对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,静脉右酮洛芬似乎在对非创伤性肌肉骨骼疼痛的镇痛方面优于静脉对乙酰氨基酚。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Although acute musculoskeletal pain has a wide range of causes from tendinitis, muscle spasm, to bone and joint injuries, it is a frequent occurrence in emergency services. Paracetamol and non-steroidal anti-inflammatory analgesics (NSAID) are common used in the treatment of musculoskeletal pain. This study sets out to compare the effectiveness of intravenous dexketoprofen and paracetamol in musculoskeletal pain relief.
METHODS: This prospective, randomized, double blind, controlled study was carried out in a university emergency room. The participating patients were randomized into two groups to receive either 50 mg of dexketoprofen or 1000 mg of paracetamol intravenously by rapid infusion in 150 ml of normal saline. Visual analogue scale (VAS), Numeric Rating Scala (NRS) was employed for pain measurement at baseline, after 15, after 30 and after 60 mins.
RESULTS: 200 patients were included in the study, excluding 7342 of them. The mean age of the patients was calculated as 32,6. Paracetamol and dexketoprofen intervention decreases NRS pain scores over time. When compared to all pain locations, the NRS pain score of the patients was found to be statistically more effective in dexketoprofen than in paracetamol (p = 0.001). Paracetamol and dexketoprofen intervention reduces pain VAS scores over time. When the VAS pain score of the patients was compared to all pain locations, dexketoprofen was found to be statistically more effective than paracetamol (p = 0.001).
CONCLUSION: Intravenous dexketoprofen seemed to achieve superior analgesia to intravenous paracetamol when compared with all pain locations in patients with non-traumatic musculoskeletal pain.
参考来源
- Demirozogul E, Yilmaz A, Ozen M, et al. Intravenous dexketoprofen versus paracetamol in non-traumatic musculoskeletal pain in the emergency department: A randomized clinical trial. Am J Emerg Med. 2019. PMID: 30744914. doi:10.1016/j.ajem.2019.01.040
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。